“The Medicines Patent Pool (MPP) and the World Health Organization (WHO), Afrigen Biologics (PTY) Limited, the Biologicals and Vaccines Institute of Southern Africa (Biovac), the South African Medical Research Council (SAMRC) and Africa Centres for Disease Control and Prevention (Africa CDC) have signed a letter of intent to address the global imbalance of manufacturing capacity for COVID-19 vaccines.”
The letter of intent sets out the terms of the collaboration and responsibilities between these organisations. It spells out responsibilities for all actors involved.
Some very specific conditions on IP matters and conditions for confidentiality.
continued
On IP:
Like others, we are keen on learning more about the companies that would share technology with the tech transfer hub.
Continues here.
To read the full story, you will need to sign up to our newsletter. While our edition on Tuesdays, The Weekly Primer is free, our exclusive analyses published in The Friday Deep Dives are behind a paywall.
Questions? Get in touch with us. [patnaik.reporting@gmail.com]
